AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Kayla E Clary

Examiner Kayla E Clary appears to be about average relative to their peer examiners. Their lifetime grant ratio is 44.9%, they average 2.15 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant 2.15
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
5 years (2022-2026)
Phone
(571) 272-2854
Predicted Supervisor
Allison Bourke
Supervisor Phone
(303) 297-4684
Tech Center
1700 - Chemical and Materials Engineering
Group
1720 - Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition

Metrics

Applications Evaluated
118
Granted Applications
53
Non-Granted Applications
65
Avg OA / Grant
2.15
Last OA Observed
March 2026 (2 months ago)
Art Units Seen
1721
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 44.9% 2.15
Art Unit 37 50.6% 2.15
Group 253 48.9% 2.20
Tech Center 1,713 47.3% 2.14
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2022; examiner may not yet have been active in the available dataset.
2022 3 1 33.3%
2023 33 22 66.7%
2024 21 14 66.7%
2025 42 16 38.1%
2026 19 0 0.0%

53 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 119 0.0% 10.1% 84.0% 0.0%
2 87 1.1% 28.7% 54.0% 4.6%
3 41 0.0% 9.8% 80.5% 2.4%
4 20 0.0% 5.0% 80.0% 0.0%
5 8 0.0% 25.0% 75.0% 0.0%
6 3 0.0% 0.0% 100.0% 0.0%
7 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2022
0.0%
2023
0.0%
2024
1.2%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.